Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue KVUE.N in a cash-and-stock deal valued at about $48.7 billion,…
Markets don’t usually hit record highs, risk falling into bearish territory, and spring back to new highs within six months.…